Concepedia

Russell Katz

RK

11

Publications

420

Citations

11

H-Index

2003

Active since

Affiliations

United States Food and Drug Administration(Current)

Pfizer (United States)

Taro Pharmaceuticals (United States)

University of Saskatchewan

The University of Texas at Austin

Russell Katz is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug development.

Top concepts

Publications per year

2003–2020

11

Publications

11

Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease

Nicholas Kozauer, Russell Katz · New England Journal of Medicine · 2013 · 193 citations

, , +16

ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE

Bruno Vellas, Randall J. Bateman, Kaj Blennow et al. · The Journal of Prevention of Alzheimer s Disease · 2015 · 45 citations · Full text

, , +10

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

James A. Hendrix, Randall J. Bateman, H. Robert Brashear et al. · Alzheimer s & Dementia · 2016 · 44 citations

, , +16

A New Approach to the Development of <scp>Disease‐Modifying</scp> Therapies for <scp>PD</scp>; Fighting Another Pandemic

Karl Kieburtz, Russell Katz, Andrew McGarry et al. · Movement Disorders · 2020 · 24 citations · Full text

Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: Workshop summary report

Mei-Ling Chen, Vinod P. Shah, Derek Ganes et al. · European Journal of Pharmaceutical Sciences · 2010 · 23 citations

, , +9

Rows per page

1–5 of 11